N-烯丙基-O-甲苯胺 | 15316-91-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-烯丙基-O-甲苯胺
• 英文名称: N-allyl-o-toluidine
• 英文别名: N-allyl-2-methylaniline；2-methyl-N-prop-2-enylaniline
• CAS: 15316-91-3
• 化学式: C₁₀H₁₃N
• 分子量: 147.22
• InChiKey: DLQNIEANPCTPPU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22,R36/37/38

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : N-Allyl-ortho-toluidine
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 15316-91-3

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Skin irritation (Category 2), H315
Eye irritation (Category 2), H319
Specific target organ toxicity - single exposure (Category 3), H335
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xi Irritant R36/37/38
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
Causes skin irritation.
Causes serious eye irritation.
May cause respiratory irritation.
Precautionary statement(s)
Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Substances
Formula : C10H13N
Molecular Weight : 147,22 g/mol
CAS-No. : 15316-91-3
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
N-Allyl-ortho-toluidine
Skin Irrit. 2; Eye Irrit. 2; STOT -
SE 3; H315, H319, H335
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
N-Allyl-ortho-toluidine
Xi, R36/37/38 -
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapours, mist or gas. Ensure adequate ventilation.
Evacuate personnel to safe areas.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Normal measures for preventive fire protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: liquid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 3,17
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
Further information
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-烯丙基-O-甲苯胺 在 三氟化硼乙醚 作用下， 以 5,5-dimethyl-1,3-cyclohexadiene 为溶剂， 反应 8.0h， 以40%的产率得到2-甲基-6-(丙-2-烯-1-基)苯胺
  参考文献：
  名称：

  通过钯催化环化 N-(2-烯丙基苯基) 苯甲酰胺合成官能化吲哚：一种合成吲哚美辛前体的方法

  摘要：

  我们开发了一种通过 Pd(II) 催化的取代 N-(2-烯丙基苯基)苯甲酰胺的 C-H 官能化合成取代 N-苯甲酰吲哚的有效方法。该反应显示出广泛的底物范围（包括 N-乙酰基和 N-Ts 底物），并且以良好到优异的产率获得了取代的吲哚。该方法最显着的特点在于对 N-苯甲酰吲哚比苯并恶嗪具有高选择性，这是 Pd(II) 催化合成取代 N-苯甲酰吲哚的第一个例子。值得注意的是，这种新方法被应用于吲哚美辛关键中间体的合成。

  DOI：

  10.3390/molecules25051233
• 作为产物：
  描述：

  邻甲苯氨基甲酸叔丁酯 在 sodium hydride 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 、 mineral oil 为溶剂， 反应 28.0h， 生成 N-烯丙基-O-甲苯胺
  参考文献：
  名称：

  氢氧化铜（II）促进了CC键的形成：羧酰胺吡啶体系与甲基亚氨基吡啶体系。

  摘要：

  通过[Cu I（py（N–C O）（N C–C）的不对称羧酰胺基-甲基亚氨基吡啶吡啶Cu（I）配合物的合成）探索了铜（II）-氢氧化物诱导的碳-碳键形成反应。ph 2 Me2）2 ] -（12）。两个亚胺基甲基偶合，在甲基位置形成桥连的C–C键（NC –CC– C – C N），同时两个Cu 2+中心离子还原为Cu +。用三种双甲酰胺基吡啶[Cu II -OH]配合物检查反应，其中双核Cu（I）[Cu 2（py（N–C O）2 ph 2 R2）2 ] 2-（R =甲基（3），甲基和烯丙基（6））和三核[Cu II –Cu I –Cu II ]复杂的[铜3（⊂ 20 -py（N-C O）2 pH值2二烯ME3）2 ] +（9）获得。的[Cu的反应性II -L（L = DMF，OH -）根据配体的电子离域特性，讨论了二甲酰胺基吡啶，甲酰胺基-甲基亚氨基吡啶和二甲基亚氨基吡啶体系中的配合物。基于

  DOI：

  10.1039/d0dt02288h

文献信息

• Synthesis of 3-bromosubstituted pyrroles via palladium-catalyzed intermolecular oxidative cyclization of bromoalkynes with N-allylamines
  作者：Jia Zheng、Liangbin Huang、Zun Li、Wanqing Wu、Jianxiao Li、Huanfeng Jiang

  DOI：10.1039/c4cc10322j

  日期：——

  This paper describes a novel palladium-catalyzed oxidative cyclization of bromoalkynes with N-allylamines via cascade formation of C-N and C-C bonds. During this process, the bromine atom was retained to form 3-bromo-pyrroles, which can undergo the subsequent structural modifications.

  本文描述了一种新的钯催化的溴炔烃与N-烯丙基胺通过CN和CC键的级联形成的氧化环化反应。在此过程中，溴原子被保留形成3-溴-吡咯，可对其进行随后的结构修饰。
• [EN] SUBSTITUTED ADIPIC ACID AMIDES AND USES THEREOF<br/>[FR] AMIDES DE L'ACIDE ADIPIQUE SUBSTITUÉS ET LEURS UTILISATIONS
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2012125622A1

  公开（公告）日：2012-09-20

  The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A is a five to eight membered monocyclic or a nine to twelve membered bicyclic heterocyclic ring, as further defined herein; Y is S, CH2, or CH; Z is CH or N; R7 and R9 are hydrogen or (C1-C6)alkyl; R2 is (C1 C6)alkoxy, OH, CN, (C1-C6)alkyl, halogen, or CF3; r and s are 0, 1, or 2; and R1 and R3 are as further defined herein. These compounds are agonists, partial agonists and/or modulators of the NPY4 receptor and may be used for the treatment and prophylaxis of obesity, food intake, and other diseases and conditions modulated by the NPY4 receptor.

  本发明提供了式（I）的化合物或其药学上可接受的盐，其中A是一个五至八元的单环或一个九至十二元的双环杂环环，如本文所进一步定义；Y是S、CH2或CH；Z是CH或N；R7和R9是氢或（C1-C6）烷基；R2是（C1-C6）烷氧基、羟基、氰基、（C1-C6）烷基、卤素或三氟甲基；r和s为0、1或2；R1和R3如本文所进一步定义。这些化合物是NPY4受体的激动剂、部分激动剂和/或调节剂，可用于治疗和预防肥胖、食物摄入和其他由NPY4受体调节的疾病和症状。
• An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis
  作者：Supaporn Sawadjoon、Joseph S. M. Samec

  DOI：10.1039/c0ob00383b

  日期：——

  The synthesis of N-aryl, N-tosyl, and N-alkyl pyrrolines from allyl alcohols and amines has been developed. The reaction sequence includes a palladium-catalyzed allylation step in which non-manipulated allyl alcohol is used to generate the diallylated amine in good to excellent yield. An excess of allyl alcohol was necessary for efficient diallylation of the amine, where the excess alcohol could be

  已经开发了由烯丙醇和胺合成N-芳基，N-甲苯磺酰基和N-烷基吡咯啉的方法。反应序列包括钯催化的烯丙基化步骤，其中使用未处理的烯丙醇以良好至极佳的产率生成二烯丙基化的胺。过量烯丙醇对于胺的有效二烯丙基化是必需的，其中过量的醇可以循环三次。对于芳基和甲苯基胺，使用Pd [P（OPh）3 ] 4；对于苄基和烷基胺，使用包含Pd（OAc）2，P n Bu 3和BEt 3的催化体系。胺的电子性质和空间影响都影响烯丙基化的效率。通过（H 2 IMes）（PCy 3）Cl 2 RuCHPh催化的闭环复分解，将分离出的二烯丙基化胺转化为它们相应的吡咯啉，收率良好。开发了一个一锅反应，其中苯胺将其转化为相应的吡咯啉，而无需分离二烯丙基化的中间体。此一锅法反应已成功放大至1 mL苯胺其中分离出N-苯基吡咯啉的产率为95％。证明了分两步制备3-甲基-1-苯基吡咯啉的反应的通用性。
• 2,4-Dinitrobenzenesulfonamides: A simple and practical method for the preparation of a variety of secondary amines and diamines
  作者：Tohru Fukuyama、Mui Cheung、Chung-Kuang Jow、Yuko Hidai、Toshiyuki Kan

  DOI：10.1016/s0040-4039(97)01334-8

  日期：1997.8

  amines and 2,4-dinitrobenzenesulfonyl chloride, can be alkylated by the Mitsunobu reaction or by the conventional methods to give N,N-disubstituted sulfonamides in excellent yields. Since 2,4-dinitrobenzenesulfonamides can be removed without deprotecting 2-nitrobenzenesulfonamides, a wide variety of diamines could be prepared by the combined use of these protecting/activating groups.

  可以容易地由伯胺和2，4-二硝基苯磺酰氯制备的2，4-二硝基苯磺酰胺可以通过Mitsunobu反应或通过常规方法进行烷基化，从而以优异的产率得到N，N-二取代的磺酰胺。由于可以在不使2-硝基苯磺酰胺脱保护的情况下除去2，4-二硝基苯磺酰胺，因此可以通过组合使用这些保护/活化基团来制备各种各样的二胺。
• Light-induced stereospecific intramolecular [2+2]-cycloaddition of atropisomeric 3,4-dihydro-2-pyridones
  作者：Elango Kumarasamy、J. Sivaguru

  DOI：10.1039/c2cc37123e

  日期：——

  Atropisomeric 3,4-dihydro-2-pyridones undergo stereospecific [2+2]-photocycloaddition in solution with high stereoselectivity (ee > 98% and de > 96%) in the product. The chiral transfer during phototransformation was rationalized based on the stability/reactivity of the biradical.

  具有固定构型的3,4-二氢-2-吡啶酮在溶液中经历立体特异性的[2+2]-光环加成反应，表现出高度的立体选择性（产物的对映体过量值大于98%，非对映体过量值大于96%）。光转化过程中的手性传递可以基于双自由基的稳定性/反应性来解释。